Trinity Biotech (TRIB) Capital Expenditures (2021 - 2024)
Historic Capital Expenditures for Trinity Biotech (TRIB) over the last 6 years, with Q4 2024 value amounting to -$157000.0.
- Trinity Biotech's Capital Expenditures rose 3720.0% to -$157000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$1.0 million, marking a year-over-year increase of 1396.93%. This contributed to the annual value of -$405000.0 for FY2024, which is 4956.41% up from last year.
- Latest data reveals that Trinity Biotech reported Capital Expenditures of -$157000.0 as of Q4 2024, which was up 3720.0% from -$250000.0 recorded in Q4 2023.
- Trinity Biotech's Capital Expenditures' 5-year high stood at -$143.0 during Q2 2022, with a 5-year trough of -$570000.0 in Q4 2021.
- Over the past 4 years, Trinity Biotech's median Capital Expenditures value was -$203500.0 (recorded in 2023), while the average stood at -$237691.5.
- Examining YoY changes over the last 5 years, Trinity Biotech's Capital Expenditures showed a top increase of 6323.91% in 2022 and a maximum decrease of 1666.67% in 2022.
- Quarter analysis of 4 years shows Trinity Biotech's Capital Expenditures stood at -$570000.0 in 2021, then grew by 16.67% to -$475000.0 in 2022, then surged by 47.37% to -$250000.0 in 2023, then skyrocketed by 37.2% to -$157000.0 in 2024.
- Its last three reported values are -$157000.0 in Q4 2024, -$250000.0 for Q4 2023, and -$128000.0 during Q3 2023.